Status:
NOT_YET_RECRUITING
Protocols for Magnesium Sulfate Maintenance Dose in Overweight and Obese Women Diagnosed With Preeclampsia
Lead Sponsor:
Ain Shams University
Conditions:
Severe Preeclampsia
Eligibility:
FEMALE
20-40 years
Phase:
PHASE1
PHASE2
Brief Summary
There is still no evidence of the appropriate dose to be used. Serum magnesium sulfate concentration is not measured regularly, thus we may be using sub-therapeutic level or reaching a toxic level.Ove...
Detailed Description
Magnesium sulfate is used in pre-eclampsia to prevent seizures, it is administered in the form of a loading dose and maintenance dose. Maintenance dose of magnesium sulfate in pre-eclampsia varies in ...
Eligibility Criteria
Inclusion
- Women diagnosed with SPET as per criteria of NICE, 2023 guidance
- Age 20-40 years
- BMI \>25kg/m2
- Gestational age \> 28 weeks
Exclusion
- Intrauterine Fetal Death (IUFD)
- Hemolysis - Elevated liver enzymes - Low platelets syndrome (HELLP)
- Contraindication to Magnesium Sulfate such as myasthenia gravis, severe renal failure, cardiac ischemia, and heart block
- Serum creatinine levels greater than 1.1 mg/dL.
- Women refusing to participate in the study.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06486025
Start Date
July 1 2024
End Date
October 1 2024
Last Update
July 3 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.